The combination of a targeted pegylation site and an appropriately-sized PEG molecule help enhance the potential of interferon therapy in the treatment of hepatitis C.
Click the links below to see: 1) The benefits of pegylation; and 2) the role that PEG molecule size plays in the ability to penetrate tissue and organs outside the liver, where hepatitis C may also reside.
Protein-to-Patient Video
| Video Segments: | |
|---|---|
| Pegylation (1min / 25sec) | |
| Biodistribution (30sec) | |
The clinical relevance of these mechanism-of-action data have not been established.
Please see the PEGINTRON® Prescribing Information.
For more information on why PEGINTRON® is the treatment choice for many hepatitis C patients, read Why Prescribe PEGINTRON®?
